USA: MedMen declares bankruptcy with 400 million dollars of debt

The North American cannabis giant MEDMAR has collapsed under the weight of its debt, announcing last week that it has declared bankruptcy and plans to liquidate its assets. On April 26, the once successful MSO (multi-state operator) announced that it has filed for bankruptcy under the Canadian Bankruptcy and Insolvency Act and that all of its directors have resigned with immediate effect, following the dismissal from your CFO in February.

Additionally, on April 23, 2024, MedMen's California-based subsidiary, MM CAN USA, was placed into receivership in Los Angeles Superior Court to dissolve and liquidate its assets.

The company's Restructuring Director resigned from his position and was appointed Judicial Administrator of MM CAN USA. Similar bankruptcy proceedings are expected to occur in other US states where the subsidiary operates.

This bankruptcy comes just six years after the company's IPO, seeing the company's value reach a peak of $3 billion in the following months. The company now leaves behind more than $400 million in debt. Like many of its peers, MedMen rode the wave of positive sentiment in 2018, seeing its share price more than double by the end of the year.

The company expanded rapidly, growing to 25 locations in California, Nevada, Illinois, Massachusetts and New York, taking on significant debt in the process. In 2019, MedMen attempted to finalize a $682 million merger with PharmaCann, which ultimately fell apart due to concerns antitrust, leaving the company struggling to pay its creditors.

Scandals continued to dog the business, leading to its founder, Sam Bierman, being ousted in 2020, embroiled in allegations of misuse of company funds. Further legal battles, accusations of racism and increasing competition from legal and illegal cannabis markets plagued MedMen during its fall from grace.

Since its peak, the company's share price has fallen by more than 90% and all but two of its stores have closed.

“The difficult decision to cease operations and initiate bankruptcy and receivership proceedings was made after careful consideration of the current financial situation of the company and its subsidiaries, its inability to pay its obligations when due and the anticipated enforcement actions of guarantee by creditors”, said the company in a press release.

“After careful consideration of these factors and in the absence of other available alternatives, the company's board of directors determined that it was in the company's best interest to proceed with the initiation of bankruptcy and receivership proceedings,” the statement ends.
___________________________________________________________
This article was originally published by Ben Stevens on Business of Cannabis

____________________________________________________________________________________________________

____________________________________________________________________________________________________

What do you do with €3 a month? Become one of our Patrons! If you believe that independent cannabis journalism is necessary, subscribe to one of the levels of our Patreon account and you will have access to unique gifts and exclusive content. If there are many of us, we can make a difference with little!

ben stevens

More postsBiography

• ben stevens

  https://cannareporter.eu/author/benstevens/

  Italy: Government uses “emergency” powers to ban hemp flower, criminalising 22.000 people overnight
• ben stevens

  https://cannareporter.eu/author/benstevens/

  UK: CBD firm sues government for £3,4m over ‘illegal’ hemp seizure
• ben stevens

  https://cannareporter.eu/author/benstevens/

  Business of Cannabis holds Berlin Executive Summit on November 26th
• ben stevens

  https://cannareporter.eu/author/benstevens/

  Thailand publishes new bill to regulate cannabis, rather than ban it completely